OR8G1 Antibody

What is OR8G1 and what is its biological function?

OR8G1 (Olfactory Receptor Family 8 Subfamily G Member 1) is a G-protein-coupled receptor that belongs to the large family of olfactory receptors. These receptors interact with odorant molecules in the nose to initiate neuronal responses that trigger smell perception. OR8G1 shares the characteristic 7-transmembrane domain structure common to many neurotransmitter and hormone receptors .

Interestingly, OR8G1 represents a polymorphic pseudogene in humans, meaning some individuals possess a functional allele encoding a full-length protein while others have a non-functional allele . This genetic variability contributes to individual differences in olfactory perception and has implications for research into sensory biology and evolution.

What are the key specifications to consider when selecting an OR8G1 antibody?

When selecting an OR8G1 antibody, researchers should consider several critical specifications:

The discrepancy between calculated (35 kDa) and observed (72 kDa) molecular weights is noteworthy and may reflect post-translational modifications, dimerization, or technical factors that should be considered when interpreting results .

How should OR8G1 antibodies be stored and handled to maintain optimal activity?

Proper storage and handling are essential for maintaining antibody performance. Based on manufacturer recommendations:

• Store concentrated OR8G1 antibodies at -20°C for long-term storage (up to one year) .

• For frequent use and short-term storage (up to one month), 4°C is acceptable .

• Avoid repeated freeze-thaw cycles as they can damage antibody structure and reduce activity .

• Most commercial OR8G1 antibodies are supplied in PBS containing protective agents:

  • 50% glycerol (cryoprotectant)

  • 0.5% BSA (stabilizer)

  • 0.02% sodium azide (preservative)

• When diluting for experiments, use fresh buffers and prepare only the amount needed.

What are the optimal dilution ratios and conditions for using OR8G1 antibodies in Western blot experiments?

Optimal Western blot conditions for OR8G1 antibodies typically include:

• Dilution range: 1:500 - 1:2000 for most commercial antibodies

• Sample preparation:

  • Use RIPA or NP-40 buffer with protease inhibitors for cell/tissue lysis

  • Denature samples at 95°C for 5 minutes in Laemmli buffer with reducing agent

• Gel electrophoresis:

  • 10-12% SDS-PAGE gels are typically suitable for the 35-72 kDa range

• Transfer conditions:

  • Semi-dry or wet transfer (wet transfer may be preferable for larger observed MW)

  • PVDF membranes are commonly used for OR8G1 detection

• Blocking:

  • 5% non-fat dry milk or BSA in TBST (1 hour at room temperature)

• Primary antibody incubation:

  • Dilute in blocking solution

  • Incubate overnight at 4°C with gentle agitation

• Signal detection:

  • Use HRP-conjugated secondary antibodies (typically anti-rabbit IgG)

  • Validate with positive controls (HT-29 cells have been used successfully)

Always optimize dilutions for your specific experimental conditions and antibody lot.

How should I design immunofluorescence experiments using OR8G1 antibodies?

For successful immunofluorescence detection of OR8G1:

• Sample preparation:

  • Cells: Fix with 4% paraformaldehyde (10-15 minutes), permeabilize with 0.1-0.3% Triton X-100

  • Tissues: Use fresh-frozen or properly fixed paraffin sections (antigen retrieval may be necessary)

• Blocking:

  • 5-10% normal serum (from secondary antibody host species) with 1% BSA

  • Include 0.1-0.3% Triton X-100 for membrane proteins like OR8G1

• Primary antibody:

  • Recommended dilution: 1:200 - 1:1000

  • Incubate overnight at 4°C in humid chamber

• Secondary antibody:

  • Fluorophore-conjugated anti-rabbit IgG

  • Typical dilution: 1:500 - 1:2000

  • Incubate 1-2 hours at room temperature

• Nuclear counterstain:

  • DAPI or Hoechst (1:1000 - 1:5000)

• Controls:

  • Include secondary-only control

  • Consider peptide competition control using the immunizing peptide

  • Include known positive tissue (olfactory epithelium) and negative controls

Since OR8G1 is a membrane protein with seven transmembrane domains, ensure adequate permeabilization and consider membrane marker co-staining to confirm localization patterns.

What validation methods should be employed to confirm OR8G1 antibody specificity?

Rigorous validation is essential for antibody-based research. For OR8G1 antibodies, consider:

• Western blot analysis:

  • Verify band at expected molecular weight (~35 kDa calculated, often observed at ~72 kDa)

  • Include positive control samples (e.g., HT-29 cells have been used)

• Peptide competition:

  • Pre-incubate antibody with excess immunizing peptide (often available from manufacturers)

  • Signal should be abolished or significantly reduced

• Genetic knockdown/knockout:

  • Compare signal in OR8G1 siRNA/shRNA treated cells vs. controls

  • CRISPR/Cas9 knockout can provide definitive validation

• Cross-reactivity assessment:

  • Test in samples from different species to confirm expected reactivity profile

  • Check for potential cross-reactivity with closely related olfactory receptors

• Multiple antibody approach:

  • Use different antibodies recognizing distinct epitopes of OR8G1

  • Consistent results with different antibodies increase confidence

• Mass spectrometry validation:

  • Immunoprecipitate with OR8G1 antibody and confirm protein identity by mass spectrometry

• Recombinant protein expression:

  • Express tagged recombinant OR8G1 and verify antibody detection

Most commercial OR8G1 antibodies undergo validation by manufacturers using methods like Western blot, IHC, ICC, immunofluorescence, and ELISA with known positive/negative samples .

Why is there a discrepancy between the calculated (35 kDa) and observed (72 kDa) molecular weight of OR8G1 in Western blots?

The observed molecular weight discrepancy for OR8G1 (calculated at ~35 kDa but often observed at ~72 kDa) can be attributed to several factors:

• Post-translational modifications:

  • Glycosylation is common in membrane proteins like GPCRs and can significantly increase apparent molecular weight

  • Phosphorylation or other modifications may alter protein migration

• Protein dimerization:

  • GPCRs like OR8G1 can form homo- or heterodimers resistant to complete denaturation

  • The ~72 kDa band may represent dimeric forms (~70 kDa theoretical for dimers)

• Technical factors:

  • Incomplete denaturation due to hydrophobic transmembrane domains

  • Anomalous migration behavior in SDS-PAGE due to protein structure

• Alternative splicing:

  • Potential detection of alternative splice variants

  • OR8G1 has been described as a polymorphic pseudogene with functional variants

• Experimental conditions:

  • Sample preparation methods and gel composition can affect migration patterns

  • Reducing conditions influence protein conformation and migration

To address this discrepancy:

• Use protein deglycosylation enzymes to assess glycosylation contribution

• Employ stronger denaturing conditions (increased SDS, urea, higher temperatures)

• Run known molecular weight markers and positive controls

• Consider alternative gel systems (e.g., gradient gels) for better resolution

What are common pitfalls in OR8G1 antibody experiments and how can they be addressed?

Common challenges in OR8G1 antibody experiments include:

For OR8G1 specifically, its polymorphic pseudogene status means expression and detection may vary between individuals, making consistent positive controls particularly important.

How should researchers interpret OR8G1 expression in non-olfactory tissues?

While traditionally associated with olfactory perception, OR8G1 and other olfactory receptors may be expressed in non-olfactory tissues. When interpreting such findings:

The detection of OR8G1 in non-olfactory contexts requires stringent validation but may reveal novel physiological roles beyond traditional olfactory function.

How can OR8G1 antibodies be utilized in studying immune system interactions and transplantation?

Research has identified OR8G1 as a potential non-histocompatibility antigen relevant to transplantation outcomes . Researchers utilizing OR8G1 antibodies in this context should consider:

• Transplant rejection studies:

  • OR8G1 has been identified among non-HLA antigen mismatched variants that may influence graft rejection

  • Antibodies can help quantify OR8G1 expression in donor and recipient tissues

  • Monitor development of anti-OR8G1 antibodies post-transplantation

• Methodological approaches:

  • Flow cytometry to assess OR8G1 expression on specific immune cell populations

  • Immunohistochemistry to evaluate OR8G1 in biopsy samples from grafts

  • Co-immunoprecipitation to identify potential OR8G1 protein interactions with immune components

• Clinical correlations:

  • Compare OR8G1 expression/variants with transplant outcomes

  • Assess whether OR8G1 antibodies correlate with rejection episodes

  • Study whether pre-existing anti-OR8G1 antibodies influence graft survival

• Genetic variant characterization:

  • Use OR8G1 antibodies in conjunction with genotyping to correlate protein expression with specific alleles

  • Determine whether certain OR8G1 variants are more immunogenic than others

This emerging research area suggests that olfactory receptors like OR8G1 may have previously unrecognized roles in immune recognition and transplant compatibility beyond traditional HLA matching .

What approaches can be used to study the polymorphic nature of OR8G1 using antibodies?

OR8G1 exists as a polymorphic pseudogene in humans, with functional and non-functional alleles across populations . To investigate this polymorphism:

• Compare expression across genotypes:

  • Use OR8G1 antibodies to assess protein expression in samples with known genotypes

  • Western blot and immunofluorescence can provide quantitative and localization data

  • Flow cytometry can enable high-throughput assessment across multiple donors

• Epitope-specific antibodies:

  • Develop or select antibodies targeting regions affected by common polymorphisms

  • Compare detection patterns using antibodies recognizing conserved versus variable regions

• Functional correlation:

  • Combine antibody-based protein detection with functional assays measuring OR8G1 activity

  • Assess whether expression levels correlate with functional responses to potential ligands

• Population studies:

  • Apply OR8G1 antibodies in immunohistochemistry or protein microarrays across diverse population samples

  • Correlate protein expression patterns with genomic data

• Antibody generation strategy:

  • Consider raising antibodies against peptides representing different OR8G1 variants

  • Use these variant-specific antibodies to differentiate between polymorphic forms

• Technical considerations:

  • Include samples with known OR8G1 genotypes as controls

  • Be aware that commercial antibodies may have differential affinity for variant forms

Understanding the relationship between OR8G1 polymorphisms and protein expression can provide insights into olfactory perception differences and potentially novel roles in non-olfactory contexts.

How can OR8G1 antibodies be integrated with large-scale antibody databases for immunological research?

Recent advances in antibody database development, such as the AbNGS database containing four billion human antibody variable region sequences , present opportunities for integrating OR8G1 antibody research:

• Structural analysis:

  • Compare anti-OR8G1 antibody sequences with the extensive antibody repertoire in AbNGS

  • Identify whether anti-OR8G1 antibodies share structural features with other antibodies

• Therapeutic antibody development:

  • Use database mining to identify naturally occurring antibodies against OR8G1

  • Assess whether anti-OR8G1 antibodies appear in public antibody repertoires across different individuals

• Immunoinformatic approaches:

  • Apply computational tools to predict OR8G1 epitopes likely to generate antibody responses

  • Compare these predictions with experimentally validated epitopes

• Cross-reactivity assessment:

  • Search for antibody sequences that might cross-react with OR8G1 and related olfactory receptors

  • Identify potential molecular mimicry between OR8G1 and other antigens

• Data mining for naturally occurring antibodies:

  • The AbNGS database contains 385 million unique complementarity-determining region (CDR)-H3s

  • Investigate whether any of these naturally occurring antibody sequences target OR8G1

Leveraging large-scale antibody databases can provide insights into the immunogenicity of OR8G1, potential cross-reactivity patterns, and guide the development of more specific research and therapeutic antibodies.

What are emerging applications of OR8G1 antibodies in understanding sensory biology and signal transduction?

OR8G1 belongs to the largest gene family in the genome (olfactory receptors) and participates in crucial sensory signal transduction processes. Advanced applications include:

• Receptor trafficking studies:

  • Use OR8G1 antibodies to track receptor localization and internalization

  • Combine with live-cell imaging techniques to study dynamic receptor movement

• Signal transduction pathway analysis:

  • Perform co-immunoprecipitation with OR8G1 antibodies to identify interaction partners

  • Use phospho-specific antibodies to monitor downstream signaling events following OR8G1 activation

• Ligand discovery:

  • Employ OR8G1 antibodies in binding displacement assays to screen potential odorant ligands

  • Use antibodies to stabilize OR8G1 for structural studies informing ligand binding sites

• Heterologous expression systems:

  • Validate OR8G1 antibodies in engineered expression systems for functional studies

  • Use antibodies to confirm successful expression and proper localization

• GPCR dimerization and complex formation:

  • Apply proximity ligation assays with OR8G1 antibodies to study receptor dimerization

  • Investigate potential heterodimeric complexes with other olfactory or non-olfactory GPCRs

• Developmental biology:

  • Track OR8G1 expression during olfactory system development

  • Correlate expression patterns with functional maturation of sensory systems

These advanced applications extend beyond simple protein detection to provide insights into the functional biology of olfactory receptors and their potentially broader roles in human physiology.

What reference materials should researchers consult when designing OR8G1 antibody experiments?

To ensure robust experimental design and interpretation when working with OR8G1 antibodies, consult:

• Protein databases:

  • UniProt (Entry: Q15617, OR8G1_HUMAN)

  • Pharos (Target ID: OR8G1)

• Antibody validation resources:

  • Manufacturer validation data for specific antibody products

  • International Working Group for Antibody Validation (IWGAV) guidelines

• Application-specific protocols:

  • Recommended dilutions for specific applications (WB: 1:500-1:2000; IF: 1:200-1:1000; ELISA: 1:20000)

• Related research:

  • Studies on OR8G1 in transplantation and immune contexts

  • Large-scale antibody database research for contextualizing findings

• Technical references:

  • Molecular weight: Calculated 35 kDa vs. observed 72 kDa

  • Immunogen information: Typically amino acids 262-311 of human OR8G1